Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096941
Status:
COMPLETED
Last Update Posted:
2015-06-11
First Post:
2004-11-17
Brief Title:
A Study to Evaluate Subjects Treated With rhuMab 2C4 Pertuzumab in a Previous Genentech Phase II Cancer Study
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-11-17
First Submit QC Date:
November 17 2004
Study First Post Date:
2004-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-06-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-29
Last Update Post Date:
2015-06-11
Last Update Post Date Type:
ESTIMATED